Cost Transparency
Makary vows FDA will uphold 'gold standard of trusted science' during Senate hearing
Lawmakers grilled Martin Makary, MD, MPH, on transparency, his plans for mifepristone and his stance on the recently cancelled Vaccine Advisory Committee meeting during Thursday’s senate hearing to be the next FDA commissioner.
Speaker: Increasing transparency during the transplant process can increase access
SCOTTSDALE, Ariz. — Providers can help increase patients’ odds of access to transplant by being transparent about candidate standards for application, according to a presenter at the Cutting Edge of Transplantation Summit.
Overweight, obesity at midlife linked to greater morbidity, health care costs later in life
Having overweight or obesity in midlife was associated with significantly higher cumulative morbidity and thousands of dollars in additional health care costs during older adulthood, data show.
Cost remains biggest barrier to dermatologic care
A rare disease diagnosis comes with significant health care costs, study shows
People with a rare disease paid three to five times more in health care costs than people without a rare disease, according to findings published in the Orphanet Journal of Rare Diseases.
Insurance deductibles may impact ED visits for chest pain, notably in lower-income areas
Individuals whose employers switched to higher deductible health plans were less likely to visit the ED for chest pain after the switch, according to data published in Circulation.
Negative impact of medical expenses high among patients with ASCVD, cancer
Difficulty paying medical bills, financial stress, cost-related nonadherence and other financial toxicities were highly prevalent among patients with atherosclerotic CVD compared with those with cancer, researchers reported.
Intracerebral hemorrhage correlates with 'significant' health care costs
Total 1-year costs associated with intracerebral hemorrhage exceeded $120 million per year, according to results of a retrospective cohort study among adult patients in Ontario, Canada that were published in Neurology.
CMS price transparency rule ‘likely insufficient’ in current form
The 2019 CMS price transparency rule did not result in uniform publication of hospital chargemasters across various NCI-designated cancer centers, according to study results published in JAMA Oncology.